Pediatric cancer gone viral. Part II: potential clinical application of oncolytic herpes simplex virus-1 in children-Reference-Cited by-同舟云学术

Pediatric cancer gone viral. Part II: potential clinical application of oncolytic herpes simplex virus-1 in children

Published:2015 Issue: Volume:2 Page:15016
ISSN:2372-7705
Container-title:Molecular Therapy - Oncolytics
language:en
Short-container-title:Molecular Therapy - Oncolytics

Author:

Friedman Gregory K,Beierle Elizabeth A,Gillespie George Yancey,Markert James M,Waters Alicia M,Chen Chun-Yu,Denton Nicholas L,Haworth Kellie B,Hutzen Brian,Leddon Jennifer L,Streby Keri A,Wang Pin-Yi,Cripe Timothy P

Funder

Virttu Biologics, Ltd

St. Baldrick's Foundation

Rally Foundation for Childhood Cancer Research

Hyundai Hope on Wheels

Vs. Cancer Foundation

Kaul Pediatric Research Institute

National Institutes of Health

Department of Defense

Nationwide Children's Hospital

Solvingkidscancer.org

Katie Linz Foundation

Alex's Lemonade Stand Foundation

Publisher

Elsevier BV

Subject

Pharmacology (medical),Cancer Research,Oncology,Molecular Medicine

Reference75 articles.

1. Pediatric cancer gone viral part I: strategies for utilizing oncolytic herpes simplex virus-1 in children;Cripe;Molecular Therapy — Oncolytics,2015

2. Evidence for an age cutoff greater than 365 days for neuroblastoma risk group stratification in the Children's Oncology Group;London;J Clin Oncol,2005

3. Second malignancies in patients with neuroblastoma: the effects of risk-based therapy;Applebaum;Pediatr Blood Cancer,2015

4. Inhibition of growth of five transplantable mouse tumors by the virus of Russian Far East encephalitis;Moore;Cancer,1951

5. Enhancement of oncolytic effect of Russian encephalitis virus;Moore;Proc Soc Exp Biol Med,1951

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Trabectedin Enhances Oncolytic Virotherapy by Reducing Barriers to Virus Spread and Cytotoxic Immunity in Preclinical Pediatric Bone Sarcoma;2024-03-03

2. Clinical advances in oncolytic virotherapy for pediatric brain tumors;Pharmacology & Therapeutics;2022-11

3. Design and Rationale for First-in-Human Phase 1 Immunovirotherapy Clinical Trial of Oncolytic HSV G207 to Treat Malignant Pediatric Cerebellar Brain Tumors;Human Gene Therapy;2020-10-01

4. Safety and efficacy of oncolytic HSV-1 G207 inoculated into the cerebellum of mice;Cancer Gene Therapy;2019-03-28

5. Stereotactic Placement of Intratumoral Catheters for Continuous Infusion Delivery of Herpes Simplex Virus -1 G207 in Pediatric Malignant Supratentorial Brain Tumors;World Neurosurgery;2019-02